{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:59:51Z","timestamp":1792706391908,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp & Dohme Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"Novartis Pharma BV","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017147","name":"Multiple Sclerosis Society UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017147","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen Idec Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012924","name":"Walton Centre NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012924","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jval.2025.07.019","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T23:56:39Z","timestamp":1754438199000},"page":"303-310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["EQ-5D-5L in Multiple Sclerosis: Estimated Utility Values, Minimal (Clinically) Important Changes, and Direct and Indirect Influences Over Time"],"prefix":"10.1016","volume":"29","author":[{"given":"Carolyn A.","family":"Young","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger J.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Tennant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Kipps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Kitley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharthan","family":"Chandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Malaspina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Paling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pat","family":"Mottram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Terrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackie","family":"Palace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Woolmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Hanneman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazen","family":"Matar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jval.2025.07.019_bib1","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.2105\/AJPH.36.11.1315","article-title":"Constitution of the World Health Organization","volume":"36","year":"1946","journal-title":"Am J Public Health Nations Health"},{"key":"10.1016\/j.jval.2025.07.019_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2025.123409","article-title":"Clinical and socio-demographic characteristics of people with multiple sclerosis at the time of diagnosis: influences on outcome trajectories","volume":"470","author":"Young","year":"2025","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.1016\/j.jval.2025.07.019_bib3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/jama.1995.03520250075037","article-title":"Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes","volume":"273","author":"Wilson","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.jval.2025.07.019_bib4","unstructured":"World Health Organization. International Classification of Functioning, Disability and Health (ICF). 1st ed Geneva: World Health Organization."},{"issue":"9","key":"10.1016\/j.jval.2025.07.019_bib5","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1287\/mnsc.22.9.990","article-title":"Health status index models: a unified mathematical view","volume":"22","author":"Torrance","year":"1976","journal-title":"Manag Sci"},{"issue":"6","key":"10.1016\/j.jval.2025.07.019_bib6","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"issue":"8","key":"10.1016\/j.jval.2025.07.019_bib7","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/00005650-198108000-00001","article-title":"The Sickness Impact Profile: development and final revision of a health status measure","volume":"19","author":"Bergner","year":"1981","journal-title":"Med Care"},{"issue":"11","key":"10.1016\/j.jval.2025.07.019_bib8","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2471\/BLT.09.067231","article-title":"Developing the World Health Organization disability assessment","volume":"88","author":"\u00dcst\u00fcn","year":"2010","journal-title":"Bull World Health Organ"},{"issue":"4","key":"10.1016\/j.jval.2025.07.019_bib9","first-page":"721","article-title":"Weighted health status in the Medicare population: development of the Weighted Health Index for the Medicare Current Beneficiary Survey (WHIMCBS)","volume":"4","author":"Doctor","year":"2000","journal-title":"J Outcome Meas"},{"issue":"3","key":"10.1016\/j.jval.2025.07.019_bib10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol-a new facility for the measurement of health-related quality of life","volume":"16","year":"1990","journal-title":"Health Policy"},{"issue":"10","key":"10.1016\/j.jval.2025.07.019_bib11","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual Life Res"},{"issue":"5","key":"10.1016\/j.jval.2025.07.019_bib12","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jval.2012.02.008","article-title":"Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets","volume":"15","author":"van Hout","year":"2012","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.jval.2025.07.019_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/hec.3564","article-title":"Valuing health-related quality of life: an EQ-5D-5L value set for England","volume":"27","author":"Devlin","year":"2018","journal-title":"Health Econ"},{"issue":"1","key":"10.1016\/j.jval.2025.07.019_bib14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.5114\/aoms.2015.52126","article-title":"EQ-5D-5L Polish population norms","volume":"13","author":"Golicki","year":"2017","journal-title":"Arch Med Sci"},{"issue":"11","key":"10.1016\/j.jval.2025.07.019_bib15","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1097\/01.mlr.0000182493.57090.c1","article-title":"Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index","volume":"43","author":"Luo","year":"2005","journal-title":"Med Care"},{"issue":"1","key":"10.1016\/j.jval.2025.07.019_bib16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12955-016-0537-0","article-title":"Health-related quality of life measured using the EQ-5D-5L: South Australian population norms","volume":"14","author":"McCaffrey","year":"2016","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"10.1016\/j.jval.2025.07.019_bib17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jval.2022.07.005","article-title":"Quality-adjusted life expectancy norms for the English population","volume":"26","author":"McNamara","year":"2023","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2025.07.019_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.675523","article-title":"Health-related quality of life in patients with different diseases measured with the EQ-5D-5L: a systematic review","volume":"9","author":"Zhou","year":"2021","journal-title":"Front Public Health"},{"issue":"2","key":"10.1016\/j.jval.2025.07.019_bib19","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/03635465211053869","article-title":"The minimal clinically important difference: a review of clinical significance","volume":"51","author":"Bloom","year":"2023","journal-title":"Am J Sports Med"},{"key":"10.1016\/j.jval.2025.07.019_bib20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1477-7525-12-66","article-title":"Estimating a minimal clinically important difference for the EuroQol 5-Dimension health status index in persons with multiple sclerosis","volume":"12","author":"Kohn","year":"2014","journal-title":"Health Qual Life Outcomes"},{"issue":"12","key":"10.1016\/j.jval.2025.07.019_bib21","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1007\/s11136-023-03486-y","article-title":"Estimating the disutility of relapse in relapsing-remitting and secondary progressive multiple sclerosis using the EQ-5D-5L, AQoL-8D, EQ-5D-5L-psychosocial, and SF-6D: implications for health economic evaluation models","volume":"32","author":"Ahmad","year":"2023","journal-title":"Qual Life Res"},{"issue":"2","key":"10.1016\/j.jval.2025.07.019_bib22","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.jval.2025.07.019_bib23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1478271520023201011","article-title":"Improving the care of patients with progressive multiple sclerosis: an evidence-based approach","volume":"32","author":"Young","year":"2002","journal-title":"Proc R Coll Physicians Edinb"},{"issue":"5","key":"10.1016\/j.jval.2025.07.019_bib24","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1177\/1352458510392262","article-title":"The relationship between fatigue and other clinical features of multiple sclerosis","volume":"17","author":"Mills","year":"2011","journal-title":"Mult Scler"},{"key":"10.1016\/j.jval.2025.07.019_bib25","series-title":"EQ-5D Value Sets: Inventory, Comparative Review and User Guide","author":"Szende","year":"2007"},{"key":"10.1016\/j.jval.2025.07.019_bib27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1477-7525-8-22","article-title":"Development of a patient reported outcome scale for fatigue in multiple sclerosis: the Neurological Fatigue Index (NFI-MS)","volume":"8","author":"Mills","year":"2010","journal-title":"Health Qual Life Outcomes"},{"issue":"6","key":"10.1016\/j.jval.2025.07.019_bib28","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1016\/j.juro.2008.08.016","article-title":"Development and validation of the short form of a urinary Quality of Life Questionnaire: SF-Qualiveen","volume":"180","author":"Bonniaud","year":"2008","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.jval.2025.07.019_bib29","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/nau.23081","article-title":"Rasch analysis of SF-Qualiveen in multiple sclerosis","volume":"36","author":"Milinis","year":"2017","journal-title":"Neurourol Urodyn"},{"issue":"11","key":"10.1016\/j.jval.2025.07.019_bib30","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1007\/s11136-023-03470-6","article-title":"Measuring disability in multiple sclerosis: the WHODAS 2.0","volume":"32","author":"Young","year":"2023","journal-title":"Qual Life Res"},{"issue":"9","key":"10.1016\/j.jval.2025.07.019_bib31","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1177\/1352458512436592","article-title":"The unidimensional self-efficacy scale for MS (USE-MS): developing a patient based and patient reported outcome","volume":"18","author":"Young","year":"2012","journal-title":"Mult Scler"},{"issue":"3","key":"10.1016\/j.jval.2025.07.019_bib32","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s12529-012-9243-4","article-title":"The stigma scale for chronic illnesses 8-item version (SSCI-8): development, validation and use across neurological conditions","volume":"20","author":"Molina","year":"2013","journal-title":"Int J Behav Med"},{"issue":"5","key":"10.1016\/j.jval.2025.07.019_bib33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.7224\/1537-2073.2018-053","article-title":"Assessing stigma in multiple sclerosis: psychometric properties of the eight-item stigma scale for chronic illness (SSCI-8)","volume":"21","author":"Ballesteros","year":"2019","journal-title":"Int J MS Care"},{"key":"10.1016\/j.jval.2025.07.019_bib34","series-title":"Society and the Adolescent Self Image","author":"Rosenberg","year":"1965"},{"key":"10.1016\/j.jval.2025.07.019_bib35","series-title":"International Encyclopedia of the Social & Behavioral Science","first-page":"15215","article-title":"Structural equation modeling","author":"Kaplan","year":"2001"},{"key":"10.1016\/j.jval.2025.07.019_bib37","series-title":"Probabilistic Models for Some Intelligence and Attainment Tests","author":"Rasch","year":"1960"},{"key":"10.1016\/j.jval.2025.07.019_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fresc.2023.1208670","article-title":"Application of the Rasch measurement model in rehabilitation research and practice: early developments, current practice, and future challenges","volume":"4","author":"Tennant","year":"2023","journal-title":"Front Rehabil Sci"},{"issue":"4","key":"10.1016\/j.jval.2025.07.019_bib39","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1177\/1352458512457840","article-title":"Perceived changes and minimum clinically important difference of the Neurological Fatigue Index for multiple sclerosis (NFI-MS)","volume":"19","author":"Mills","year":"2013","journal-title":"Mult Scler"},{"key":"10.1016\/j.jval.2025.07.019_bib40","article-title":"Evaluating the credibility of anchor based estimates of minimal important differences for patient reported outcomes: instrument development and reliability study","volume":"369","author":"Devji","year":"2020","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.jval.2025.07.019_bib41","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2522\/ptj.20080258","article-title":"Test-retest reliability and minimal detectable change scores for the timed \u201cup & go\u201d test, the six-minute walk test, and gait speed in people with Alzheimer disease","volume":"89","author":"Ries","year":"2009","journal-title":"Phys Ther"},{"key":"10.1016\/j.jval.2025.07.019_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.105115","article-title":"Multiple sclerosis vision questionnaire (MSVQ-7): reliability, validity, precision and discrimination","volume":"80","author":"Young","year":"2023","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.jval.2025.07.019_bib43","series-title":"Stata. Stata Statistical Software. Release 18","year":"2023"},{"issue":"1","key":"10.1016\/j.jval.2025.07.019_bib45","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13690-021-00561-z","article-title":"Health-related quality of life of multiple sclerosis patients: a European multi-country study","volume":"79","author":"Visser","year":"2021","journal-title":"Arch Public Health"},{"issue":"5","key":"10.1016\/j.jval.2025.07.019_bib46","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1017\/S0266462318000557","article-title":"Differentiation of health-related quality of life outcomes between five disease areas: results from an international survey of patients","volume":"34","author":"Efthymiadou","year":"2018","journal-title":"Int J Technol Assess Health Care"},{"issue":"2","key":"10.1016\/j.jval.2025.07.019_bib47","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s11136-022-03214-y","article-title":"Validation of the EQ-5D-5L and psychosocial bolt-ons in a large cohort of people living with multiple sclerosis in Australia","volume":"32","author":"Campbell","year":"2023","journal-title":"Qual Life Res"},{"issue":"6","key":"10.1016\/j.jval.2025.07.019_bib48","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s10198-022-01518-x","article-title":"Using the EQ-5D-5L to investigate quality-of-life impacts of disease-modifying therapy policies for people with multiple sclerosis (MS) in New Zealand","volume":"24","author":"Claflin","year":"2023","journal-title":"Eur J Health Econ"},{"key":"10.1016\/j.jval.2025.07.019_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104795","article-title":"Quality of life of MS patients in Trinidad and Tobago: anomaly or adaptation?","volume":"76","author":"Bailey","year":"2023","journal-title":"Mult Scler Relat Disord"},{"issue":"2","key":"10.1016\/j.jval.2025.07.019_bib50","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/1352458513507818","article-title":"Effects of BG-12 (dimethyl fumarate) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM study","volume":"20","author":"Kita","year":"2014","journal-title":"Mult Scler"},{"issue":"2","key":"10.1016\/j.jval.2025.07.019_bib51","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/1352458513507817","article-title":"Quality of life outcomes with BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: the DEFINE study","volume":"20","author":"Kappos","year":"2014","journal-title":"Mult Scler"},{"issue":"10","key":"10.1016\/j.jval.2025.07.019_bib52","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1177\/1352458516677589","article-title":"Alemtuzumab improves quality-of-life outcomes compared with subcutaneous interferon beta-1a in patients with active relapsing-remitting multiple sclerosis","volume":"23","author":"Arroyo Gonz\u00e1lez","year":"2017","journal-title":"Mult Scler"},{"key":"10.1016\/j.jval.2025.07.019_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104550","article-title":"Patient reported outcomes in a secondary progressive MS cohort related to cognition, MRI and physical outcomes","volume":"71","author":"Theodorsdottir","year":"2023","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.jval.2025.07.019_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104154","article-title":"Psychological flexibility, distress, and quality of life in secondary progressive multiple sclerosis: a cross-sectional study","volume":"67","author":"Meek","year":"2022","journal-title":"Mult Scler Relat Disord"},{"issue":"8","key":"10.1016\/j.jval.2025.07.019_bib55","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1177\/1352458520958369","article-title":"Feelings of depression, pain and walking difficulties have the largest impact on the quality of life of people with multiple sclerosis, irrespective of clinical phenotype","volume":"27","author":"Zhang","year":"2021","journal-title":"Mult Scler"},{"key":"10.1016\/j.jval.2025.07.019_bib56","article-title":"Perceived cognitive decline in multiple sclerosis impacts quality of life independently of depression","volume":"2014","author":"Samartzis","year":"2014","journal-title":"Rehabil Res Pract"},{"key":"10.1016\/j.jval.2025.07.019_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105675","article-title":"Association of patient-reported cognitive impairment with quality of life and employment in multiple sclerosis","volume":"87","author":"Lancia","year":"2024","journal-title":"Mult Scler Relat Disord"},{"issue":"5","key":"10.1016\/j.jval.2025.07.019_bib58","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1177\/135245850100700511","article-title":"Quality of life in multiple sclerosis: the impact of depression, fatigue and disability","volume":"7","author":"Amato","year":"2001","journal-title":"Mult Scler"},{"issue":"1","key":"10.1016\/j.jval.2025.07.019_bib59","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1186\/s12889-024-18807-0","article-title":"Structural relations of illness perception, fatigue, locus of control, self-efficacy, and coping strategies in patients with multiple sclerosis: a cross-sectional study","volume":"24","author":"Akbari Esfahani","year":"2024","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jval.2025.07.019_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105661","article-title":"The impact of bladder problems on well-being in multiple sclerosis-a cross-sectional study","volume":"87","author":"Islamoska","year":"2024","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"10.1016\/j.jval.2025.07.019_bib61","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1186\/s12883-023-03395-0","article-title":"Social stigma and its relationship with quality of life in multiple sclerosis patients","volume":"23","author":"Sharifi","year":"2023","journal-title":"BMC Neurol"},{"key":"10.1016\/j.jval.2025.07.019_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104608","article-title":"Healthier living with MS: the key role of self-efficacy and emotion regulation","volume":"73","author":"Dehghan","year":"2023","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.jval.2025.07.019_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinepi.2024.111487","article-title":"Systematic review reveals that EQ-5D minimally important differences vary with treatment type and may decrease with increasing baseline score","volume":"174","author":"Cheng","year":"2024","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"10.1016\/j.jval.2025.07.019_bib64","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jval.2024.11.006","article-title":"A systematic literature review of important and meaningful differences in the EQ-5D index and visual analog scale scores","volume":"28","author":"Al Sayah","year":"2025","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2025.07.019_bib65","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1477-7525-11-59","article-title":"Minimal clinically important differences for the EQ-5D and QWB-SA in Post-traumatic Stress Disorder (PTSD): results from a Doubly Randomized Preference Trial (DRPT)","volume":"11","author":"Le","year":"2013","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"10.1016\/j.jval.2025.07.019_bib66","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jclinepi.2007.03.012","article-title":"Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes","volume":"61","author":"Revicki","year":"2008","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"10.1016\/j.jval.2025.07.019_bib67","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/S0277-9536(99)00045-3","article-title":"Integrating response shift into health-related quality of life research: a theoretical model","volume":"48","author":"Sprangers","year":"1999","journal-title":"Soc Sci Med"},{"issue":"1","key":"10.1016\/j.jval.2025.07.019_bib68","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/hec.3564","article-title":"Valuing health-related quality of life: an EQ-5D-5L value set for England","volume":"27","author":"Devlin","year":"2018","journal-title":"Health Econ"},{"issue":"2","key":"10.1016\/j.jval.2025.07.019_bib69","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s40273-022-01218-7","article-title":"Estimating the relationship between EQ-5D-5L and EQ-5D-3L: results from a UK population study","volume":"41","author":"Hern\u00e1ndez Alava","year":"2023","journal-title":"Pharmacoeconomics"},{"issue":"8","key":"10.1016\/j.jval.2025.07.019_bib70","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jval.2019.02.009","article-title":"United States valuation of EQ-5D-5L health states using an international protocol","volume":"22","author":"Pickard","year":"2019","journal-title":"Value Health"},{"issue":"11","key":"10.1016\/j.jval.2025.07.019_bib71","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.jval.2023.08.005","article-title":"UK valuation of EQ-5D-5L, a generic measure of health-related quality of life: a study protocol","volume":"26","author":"Rowen","year":"2023","journal-title":"Value Health"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301525024866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301525024866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:21:25Z","timestamp":1769127685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301525024866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1098301525024866"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2025.07.019","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EQ-5D-5L in Multiple Sclerosis: Estimated Utility Values, Minimal (Clinically) Important Changes, and Direct and Indirect Influences Over Time","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2025.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}